News
An international study with the participation of IDIBELL shows that the drug semaglutide, for obesity and diabetes, protects the kidney in obese people with kidney disease
The novel results have been presented at the Kidney Week 2024 Congress of the American Society of Nephrology, in San Diego, and have been published simultaneously in the prestigious journal Nature Medicine. In Spain, 40% of the population is overweight, 22% of the population is obese and 3 out of 10 patients with chronic kidney disease suffer from obesity.
According to a European survey, only 6 of every 10 Spanish houses are smoke-free
Seven out of ten homes in Europe are smoke-free, according to a major survey published today in ERJ Open Research.
In Romania, Bulgaria and Spain, more than four in ten homes allow smoking to take place, while England scored highest with more than eight in ten homes smoke-free.
The second RegenBell Symposium on stem cells and regenerative medicine takes place
The main objective of this conference is to establish a platform for discussion and ideaexchange between professionals in the subject. 11 conferences were presented, 8 selected short talks, and 39 posters, all around stem cells and regenerative medicine.
Celebration of the homage to Dr. Virginia Nunes
Participants shared their knowledge and experiences on human genetics, rare diseases, and Dr. Virginia Nunes’ legacy in these fields.
The Marató 3Cat finances three IDIBELL projects in sexual and reproductive health
Drs. Laia Alemany, Mireia Martín Satué, Jordi Guiu and Gabriel Capellá will carry out their research projects in sexual and reproductive health thanks to the funds raised by La Marató 2023.
Researchers identify inflammatory markers related to the prognosis of breast cancer
A study by IDIBELL, ICO and IARC has linked the levels of certain inflammatory molecules with mortality in breast cancer patients.
The study, published in the British Journal of Cancer, included 1538 women from eight countries belonging to the EPIC cohort and diagnosed with breast cancer.
Admit therapeutics receives accreditation from college of american pathologists
The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to ADmit Therapeutics, Barcelona, Spain based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved […]
Aurora Pujol receives funding from the CaixaResearch call for Health Research 2024
The project aims to find a cure for a lethal degenerative genetic disease that affects children, adrenoleukodystrophy.
Researchers identify a potential biomarker of Parkinson’s disease progression
Researchers from IDIBELL and the UB show that the levels of a certain neuronal receptor are increased only in patients with a slow progression of this pathology.